Prenatal PFAS Exposure: New Research Reveals Wider Impact on Infant Health

Babies are exposed to a surprisingly diverse and substantial array of “forever chemicals” in the womb, according to a new study published in Environmental Science & Technology. Researchers have discovered that standard testing methods significantly underestimate the extent of prenatal exposure to per- and polyfluoroalkyl substances (PFAS), raising concerns about potential health impacts on children.

What are PFAS and Why are They a Concern?

PFAS are a large group of synthetic chemicals used in countless consumer and industrial products, including nonstick cookware, stain-resistant fabrics, food packaging, and firefighting foams . Often referred to as “forever chemicals” due to their persistence in the environment and the human body, PFAS can accumulate over time and have been linked to a range of health problems, though the full extent of their effects is still being investigated .

New Research and Advanced Detection Methods

Led by Shelley H. Liu, PhD, Associate Professor of Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai, the study utilized a novel data science-based approach and advanced chemical analysis of umbilical cord blood samples . Researchers analyzed samples collected between 2003 and 2006 from 120 babies participating in the Cincinnati-based HOME Study. Unlike traditional testing, which focuses on a limited number of known PFAS compounds, this study employed a non-targeted chemical analysis method, scanning for hundreds to thousands of chemicals simultaneously.

Key Findings: 42 PFAS Compounds Detected

The advanced analysis revealed 42 confirmed or potentially identified PFAS chemicals in the cord blood samples . Many of these substances are not routinely measured in standard testing panels, highlighting a significant gap in our understanding of prenatal PFAS exposure. The detected PFAS included perfluorinated chemicals, polyfluorinated chemicals, and fluorotelomers.

PFAS-Omics Burden Scores and Exposure Patterns

To provide a comprehensive measure of overall exposure, the researchers developed “PFAS-omics” burden scores using item response theory methods. Interestingly, the study did not find significant differences in PFAS exposure between babies born to first-time mothers and those born to mothers with previous pregnancies – a finding that contrasts with some earlier research relying on narrower PFAS panels . Dr. Liu emphasized that the method of measurement significantly impacts the results, revealing a more extensive exposure than previously recognized.

Why Prenatal Exposure Matters

Pregnancy represents a critical window of development, and previous research has linked prenatal PFAS exposure to several adverse health outcomes, including low birth weight, preterm birth, altered immune responses to vaccines, and metabolic changes . Understanding the full scope of prenatal PFAS exposure is crucial for protecting child health and mitigating preventable environmental risks.

Implications for Clinical Care and Future Research

Currently, PFAS exposure is not routinely measured in clinical settings. However, the new approach developed by Dr. Liu’s team offers a way to more fully estimate cumulative PFAS exposure, potentially aiding clinicians in identifying high-exposure individuals, monitoring at-risk populations, and informing preventive medicine strategies .

The research team plans to investigate the association between cumulative PFAS exposure in early life and long-term health outcomes. They also aim to study the potential health effects of newly identified and understudied PFAS compounds found in cord blood and refine tools for primary disease prevention .

Emerging PFAS and Potential Autoimmune Links

Further research, including analysis of serum samples collected between 2003 and 2021, has revealed a concerning increase in emerging replacement PFASs, such as 9Cl-PF3ONS and polyfluoroalkyl phosphate species . Researchers also documented the presence of a novel PFAS, chloroperfluorononylphosphonic acid (Cl-PFNPA), in human serum. While no discernible link was found between PFAS exposure and autoimmune disease in this particular study, the temporal trends in emerging PFASs warrant further investigation .